Dexcom Inc (DXCM)
$133.86
2.66 (1.95%)
DXCM Stock Quote Delayed 30 Minutes
Top 5 Stocks for 2024
INSIDE: Investing legend Louis Navellier reveals his Top 5 Stocks for 2024 — FREE!
Download His Free Report Here:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
-
Market Cap
12.95B
PE Ratio
102.97
EPS
1.3
Volume (Avg. Vol.)
3.22M
Day's Range
$132.88 - $136.64
52-Week Range
$74.75 - $142.00
Dividend & Yield
N/A (N/A)
DXCM Stock Predictions, Articles, and Dexcom Inc News
Which Biotech Stocks Are a Buy on Earnings?
If you’re interested in high-growth biotech stocks with superior fundamentals, here are which ones to consider, and which ones to skip.
3 Great Growth Stocks That Kept Climbing in This Tough Market
While many companies were unable to avoid the wrath of the coronavirus pandemic, these three companies stood out as big winners.
3 Big Stock Charts for Monday: Twitter, UnitedHealth Group and Philip Morris
The stock charts of UNH, TWTR and PM are poised to start the new trading week on the verge of big moves. Here are the levels to keep an eye on.
2 Internet of Things Stocks to Buy for the Connected Future
These Internet of Things stocks should be on your stocks to buy list as they have slipped under the radar and continue to present unique long-term opportunities in the IoT space.
DexCom Stock Skyrockets on Q2 Earnings Beat
DexCom (DXCM) stock was on the rise Thursday following the release of a strong earnings report for the second quarter of 2018.
5 MedTech Stocks That Perfectly Blend Healthcare and Technology
MedTech Stocks are hot, hot, hot. Here are five of the best to buy today for long-term growth.
This Is Not the End of the World for Fitbit Inc Stock
Another dip in quarterly sales and profits confirms the worst fears for Fitbit stock holders as Fitbit Inc just can't find its lane.
Fitbit for Kids? FIT Considering Smartwatch for Children
Fitbit (FIT) is reportedly working on a version of Fibit for kids, but the device is still in the early stages of development.
Fibit Inc Invests in Blood Glucose Monitoring Startup
The Fitbit investment in Sanos, a startup developing a coin-sized blood glucose monitor for diabetics, is proof that Fitbit has no intention of letting Apple dominate the health tracking market the same way it took over the smart watch market.
Fitbit Inc (NYSE:FIT) Stock Still Has A Lot of Work To Do
Fitbit stock hit an eight-month high before a recent pullback. But the "this time is different" story behind FIT stock isn't strong enough.
Why Fitbit Inc (FIT) Stock Is Rising on the Latest Ionic Update
Fitbit stock got another boost on news it inked a deal with Dexcom to bring CGM data for diabetics to the Fitbit Ionic smartwatch.
